Crossmark

MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer

Crossref DOI link: https://doi.org/10.1186/1471-2407-14-837

Published Online: 2014-11-18

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pénzváltó, Zsófia

Lánczky, András

Lénárt, Julianna

Meggyesházi, Nóra

Krenács, Tibor

Szoboszlai, Norbert

Denkert, Carsten

Pete, Imre

Győrffy, Balázs
License Information

License valid from 2014-11-18
More Information

Article History

Received: 1 May 2014

Accepted: 4 November 2014

First Online: 18 November 2014